Pharmaceutical compound
Identifiers | |
---|---|
IUPAC name
| |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C21H24BrN3O3S |
Molar mass | 478.41 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Masupirdine is an investigational new drug that is being evaluated for the treatment of agitation in Alzheimer's dementia. It is a selective 5-HT6 receptor antagonist.
References
- "Masupirdine - Suven Life Sciences". AdisInsight. Springer Nature Switzerland AG.
- Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, et al. (February 2023). "Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders". Biomolecules. 13 (2): 309. doi:10.3390/biom13020309. PMC 9953539. PMID 36830678.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |